Novartis AG (NYSE:NVS – Get Free Report) has been given a consensus recommendation of “Hold” by the eleven ratings firms that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating on the […]
Paradigm Asset Management Co. LLC lessened its stake in shares of Novartis AG (NYSE:NVS – Free Report) by 2.4% during the first quarter, Holdings Channel.com reports. The fund owned 4,113 shares of the company’s stock after selling 100 shares during the period. Paradigm Asset Management Co. LLC’s holdings in Novartis were worth $378,000 at the […]
Mar Vista Investment Partners LLC Grows Position in Novartis AG (NYSE:NVS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, Aug. 14, 2023 (GLOBE NEWSWIRE) Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced the appointment of Brian Powl as Chief Commercial Officer. Mr. Powl joins Kura with more than 20 years of experience in building commercial brands in hematology and oncology, with a focus on developing and executing patient-focused strategies across sales, marketing and ma